An Open-label, Single Center, Randomized, Two Period Study to Characterize the Safety, Tolerability and Pharmacokinetics (PK) of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers
Phase of Trial: Phase I
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Estetrol (Primary)
- Indications Menopause; Pregnancy
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Estetra S.A.
- 07 Sep 2017 Status changed from recruiting to completed.
- 14 Mar 2017 New trial record